Anthropy23 returned to The Eden Project in Cornwall for its second year in November, once more bringing together cross-industry companies and individuals united in a shared goal: to seek su
Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical produc
Cell and gene therapies (CGT) offer immense potential for healthcare – opening up countless possibilities for saving and improving lives, which were previously unavailable through existing
